Click here to see this online

March 30, 2017


Invitation for Cancer Nanotechnology Researchers to Present at ACS National Meeting

A call for abstracts is open for researchers in cancer nanotechnology (especially graduate students) at the upcoming American Chemical Society (ACS) summer meeting in Washington DC, from August 20-24, 2017.

The session is titled “Nanotheranostics for Cancer Applications” and is co-chaired by Ramanathan Nagarajan and Dr. Stephanie Morris, a Program Director from NCI’s Office of Cancer Nanotechnology Research. The focus will be on applications of multifunctional nanoparticles in oncology, with a planned mix of established scientist and trainee presentations (graduate students/postdoctoral fellows). This would be a fantastic opportunity to share the cancer nanotechnology work being conducted at Illinois with the ACS community. Travel awards are available to graduate students and postdocs.

A PDF with more detail can be found here. The abstracts submission site can be reached here. The submission deadline is Monday, April 10.

 Faculty Seminar Poster

Cancer Community at Illinois Faculty Seminar Series

The Cancer Community at Illinois Faculty Seminar Series continues with a session the first week of April.

Thursday, April  6 | 3:00 p.m. - 4:30 p.m.
Health Care Engineering Systems Center (HCESC), Room 1232
(HCESC is in the lower level of the North Campus Parking Deck Building at 1206 W Clark Street, Urbana, IL)

This month's speakers and talk titles are:

  • Rohit Bhargava (Bioengineering)
    •    “Chemical Imaging for Digital Molecular Pathology”
  • Rex Gaskins (Animal Sciences)
    •    “Microbial Sulfur Metabolism and Colorectal Cancer Risk”
  • Edward Roy (Pathology)
    •    “Immunotherapy of Gliomas”
  • T. Kesh Keshavadas (HSESC)
    •    “Precision Surgery Through Robotics”

Please RSVP at


Request for Faculty Achievements and Publications

The Cancer Community at Illinois is publishing a list of faculty achievements from June 2016 to present in the next issue of Pathways. As you know, our community members have a very active record of achievement and publication, which we aim to celebrate.

Please send us the following information for you or your lab:

  • Selected Honors and Awards
    • Provide the name of the award and the honor granting organization.
  • Selected Grants
    • Provide the name of the granting organization, the title of the proposal, and the dates indicating the length of the grant.
  • Publications
    •  In order to render the list manageable, we are allotting no more than five (5) entries per faculty member. If you would like your work to appear in the next Pathways, please select the five publications you would most like to highlight among those you have published during the academic year. Please note that forthcoming publications are not eligible for inclusion this round.

If you have received ANY awards/acknowledgements/honors and/or published books or articles during this time, send the information/citation(s) to



 Dr. James R. Heath
 Dr. James R. Heath

Pioneers in Bioengineering Lecture Series

The Pioneers in Bioengineering Lecture Series is bringing Dr. James R. Heath, professor of chemistry at Caltech, to campus next week.

Tuesday, April  4 | Noon
Micro + Nanotechnology Lab, Room 1000

Dr. James R. Heath
Elizabeth W. Gilloon Professor of Chemistry
California Institute of Tech
"Technologies for Personalizing Cancer Immunotherapies"

 Save the Date CSTAR

RSVP for the April 19 CSTAR Reception

The CSTAR program will be holding a reception April 19, 2017. This is a great opportunity for faculty, students, and physicians to learn more about the exciting research happening in the CSTAR program.

Carle and Illinois Reception
April 19, 2017
4:00 - 6:00 p.m.
Mills Breast Cancer Center
Carle Houseworth Conference Center (2nd floor)

Please RSVP by Noon on April 14, 2017.


Carle Cancer Research Update Meeting

Join the discussion at the Carle Cancer Research Update Meeting. This week Sinisa Stanic, MD, will present "Hippocampal Avoidance in Patients with Brain Metastases." Lunch is not served, but you are welcome to bring your own lunch if you would like.


"Hippocampal Avoidance in Patients with Brain Metastases"


Sinisa Stanic, MD


March 31, 2017
Noon-12:30 p.m. CST


Carle Cancer Center/MBCI-2nd Floor
Houseworth Conference Room




FDA Scientific Conference Grant Program (R13/U13)

The purpose of the FDA (R13) Conference Grant and (U13) Cooperative Agreement is to facilitate the provision of federal financial assistance in support of small conferences and scientific meetings clearly aligned with the FDA mission. Prior approval (advance permission) is required before submission of an application for conference support. Advance permission to submit an application must be requested early in the process and no later than 8 weeks before the application submission date. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.Complete RFP.

Deadline: June 16, 2017.

Complete RFP



 DNA from tumour cells is known to end up in the bloodstream in the earliest stages of cancer so offers a unique target for early detection of the disease. (stock image) Credit: © vchalup / Fotolia
 DNA from tumour cells is known to end up in the bloodstream in the earliest stages of cancer so offers a unique target for early detection of the disease. (stock image) Credit: © vchalup / Fotolia

Computer Program Developed to Diagnose and Locate Cancer from a Blood Sample

Science Daily — Researchers have developed a computer program that can simultaneously detect cancer and identify where in the body the cancer is located, from a patient's blood sample. The program is described in research published this week in the open access journal Genome Biology.

Professor Jasmine Zhou, co-lead author from the University of California at Los Angeles, said: “Non-invasive diagnosis of cancer is important, as it allows the early diagnosis of cancer, and the earlier the cancer is caught, the higher chance a patient has of beating the disease. We have developed a computer-driven test that can detect cancer, and also identify the type of cancer, from a single blood sample. The technology is in its infancy and requires further validation, but the potential benefits to patients are huge.”

Read the full story here.


Visit our Events Calendar for a complete list of upcoming cancer-related activities and events.